Trial intelligence / Profile preview

Ulinastatin Preconditioning in Preterm Infants With Birth Asphyxia

ChiCTR2100046962Phase 4Completed

Sponsor
People's Hospital of Wuhan University
Start
Jan 2019
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of ulinastatin in asphyxia neonatorum (2 arms), sponsored by People's Hospital of Wuhan University. Primary endpoints: Serum IL-6 level, Serum S100β protein level and 1 more. Started Jan 2019; status: completed.

02

Drugs

ulinastatin
03

Conditions

asphyxia neonatorum

Beyond the preview

Go deeper on ChiCTR2100046962.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100046962.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call